2363results about How to "Pain relief" patented technology

A method and apparatus particularly useful for pain control by selectively blocking the propagation of body-generated action potentials travelling through a nerve bundle by using a tripolar electrode device to generate unidirectional action potentials to serve as collision blocks with the body-generated action potentials representing pain sensations in the small-diameter sensory fibers. In the described preferred embodiments there are a plurality of electrode devices spaced along the length of the nerve bundle which are sequentially actuated with delays corresponding to the velocity of propagation of the body-generated action potentials through the large-diameter fibers to produce a "green wave" effect which minimizes undesired anodal blocking of the large-diameter fibers while maximizing the collision blocking of the small-diameter fibers.

A blood withdrawal system for producing blood from a body part for diagnostic purposes, comprising a housing with a lancet guide capable of guiding a lancet on a predetermined puncturing path and a lancet drive for driving a puncturing movement of a lancet on the predetermined path. The lancet drive comprises a drive rotor driven by a drive spring and rotates about an axis during the puncturing movement, and a coupling mechanism which converts the rotational movement of the drive rotor into a puncturing movement, wherein the lancet is moved during a forward phase of the puncturing movement in the puncturing direction until its tip penetrates into the body part to create a wound and is retracted from the skin during a retraction phase of the puncturing movement. The coupling mechanism includes a translation element coupled to the lancet and guided by a guide on a movement path.

A tip portion or endcap for a lancing device having a non-circular opening to provide tension and pressure upon the patient's skin before and/or during lancing of the skin for sample collection. In example embodiments, the endcap is shaped to prevent the lancet body from sticking within the hole or passing through the hole. The endcap may also be shaped to allow it to be used at various lancing sites on the body without changing the endcap.

An ultrasonic medical treatment device has a probe, a transducer for mechanically vibrating the probe at an ultrasonic frequency, a voltage source for energizing the transducer, and another electrical voltage source for feeding to the probe a high-frequency alternating waveform of limited current and limited voltage to be conducted into a patient through the operative tip of the probe after placement of the operative tip into contact with the patient. The alternating waveform has a current and a voltage so limited as to prevent damage to organic tissues while stimulating nerves to reduce or suppress pain.

A method of training a biological neural network using a controller, comprising:

• • applying a cycle comprising:
    • stimulating a neural network by said controller applying at least an input signal to the network;
    • detecting an output response of the network by said controller; and
    • modifying said stimulation by said controller for at least a period of time if said response matches a desired at least approximate response; and
  • repeating said cycle of stimulation, detection and modification at least one more time until said neural network is trained to generate a desired output response for said input signal.

Embodiments of the present invention provide systems and methods for the treatment of pain through activation of select neural fibers. The neural fibers may comprise one or more afferent neural fibers and/or one or more efferent neural fibers. If afferent fibers are stimulated, alone or in combination with efferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate afferent pathways in a manner approximating natural afferent activity. The afferent fibers may be associated with primary receptors of muscle spindles, golgi tendon organs, secondary receptors of muscle spindles, joint receptors, touch receptors, and other types of mechanoreceptors and/or proprioceptors. If efferent fibers are stimulated, alone or in combination with afferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate intrafusal and/or extrafusal muscle fibers, which results in an indirect activation of afferent fibers associated therewith.

The invention relates to a traditional Chinese medicine composition for treating burn, comprising an oral medicine and an externally applied medicine, wherein the oral medicine is prepared from angelica sinensis, hemlock parsley, astragali, pseudo-ginseng, sanguisorba, safflower, radix rehmanniae, spatholobus stem, baikal skullcap root, giant knotweed, oldenlandia diffusa, dangshen, tuckahoe, white atractylodes rhizome and red peony root; and the externally applied medicine is prepared from myrrh, mastic, rhubarb, pseudo-ginseng, safflower, draconis sanguis, natural indigo, gromwell, fried sanguisorba, giant knotweed, carpet bugle, borneol and phellodendron bark. The traditional Chinese medicine composition provided by the invention is convenient to use and coat on an affected part for skin absorption, is easy to wash off and convenient to change dressing, can keep the surface of a wound wet, can prevent bacterial invasion, is capable of quickly alleviating pain, diminishing inflammation and relieving itching, and can promote the surface of a wound to heal quickly and reduce scar. In addition, the traditional Chinese medicine composition has short period of treatment, an obvious curative effect and no obvious toxic or side effect, has obvious efficacies of antibiosis, alleviating pain, subduing swelling, diminishing inflammation, adsorbing, converging, removing necrosis and promoting granulation, and is used through oral administration and external application with quite good effect.

The present invention relates to methods and compositions for treating selected conditions of the central and peripheral nervous systems employing non-synaptic mechanisms. More specifically, one aspect of the present invention relates to methods and materials for treating seizure and seizure disorders, epilepsy, status epilepticus, migraine, spreading depression, intracranial hypertension; for treating the pathophysiological effects of head trauma, stroke, ischemia and hypoxia; for treating or protecting from the pathophysiological effects of neurotoxic agents such as ethanol; and for treating neuropsychiatric disorders and central nervous system edema by administering agents that modulate ionic concentrations and/or ionic gradients in the brain, particularly ion-dependent or cation-chloride cotransporter antagonists. Electrolyte cotransport antagonists and combinations of such compositions with other agents for treating various conditions are disclosed.

A vibrating tourniquet is disclosed in which one or more vibrating devices are coupled within a pliable strap portion and are activated to interrupt nerve transmissions, and supply an alternative stimulus, that decreases the sensation of pain as the needle or IV are introduced through the skin and into a vein. The vibration devices are electrically coupled to a controller mechanism and the controller mechanism may be turned on or off after the tourniquet is applied to the arm. In alternative versions, the frequency and amplitude of the vibration may be selectively increased or decreased cooperatively or separately by adjusting the controller mechanism as needed.

The present invention relates to a method of altering the refractive properties of the eye, the method including forming a pocket in a cornea of an eye of a patient so as to gain access to tissue bounding the pocket; after the pocket in the cornea has been formed, applying a photosensitizer inside the pocket so that the photo sensitizer permeates at least a portion of the tissue bounding the pocket, the photosensitizer facilitating cross-linking of the tissue bounding the pocket; inserting a lens implant into the pocket so as to change the refractive properties of the eye; and irradiating the cornea so as to activate cross-linkers in the portion of the tissue bounding the pocket and thereby stiffen the cornea and prevent corneal ectasia of the cornea.

An injection aid for a syringe includes a disk with a central orifice and a flange. The flange is located on the top of the disk, and surrounds the central orifice. The outlet end or needle hub of a syringe or insulin pen fits in the flange, with the syringe needle extending through the orifice, thereby securing the disk to the syringe. The bottom surface of the disk is generally flat. The bottom surface of the disk makes contact with the skin when the needle is inserted to the proper depth. In other words, the needle lies perpendicular to the disk and is arranged to project past the disk's flat bottom surface by a set, pre-determined length. When the disk is pressed flat against a patient's skin, the needle is at the proper depth for the substance being injected.